Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2025-12-25 @ 12:08 AM
NCT ID:
NCT03146858
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18
* Confirmation of the diagnosis of STEMI by the clinical team on the basis of history, ECG changes and angiographic findings
* Pre-treatment with either ticagrelor or prasugrel
* Intention to proceed with PPCI
* Feasibility to obtain informed verbal consent pre PPCI
Exclusion Criteria:
* Active bleeding that cannot be controlled by local measures
* Female patients of child bearing age who have not had a sterilisation procedure
* Patients with end stage renal failure requiring renal replacement therapy
* Known thrombocytopenia (Platelet count \< 100,000/μL)
* Known history of intracranial haemorrhage
* Known current treatment with oral anticoagulants
* Known history of major surgery or trauma or history of GI/GU haemorrhage within the last month
* Known intracranial malignancy or aneurysm
* Known allergy to enoxaparin
* Inability to easily understand verbal information given in English for any reason
* Inability to give informed consent due to either temporary or permanent mental incapacity
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03146858
Study Brief:
Protocol Section:
NCT03146858